11,Mafson EJ. Conner JM. Kordower JH. Nerve growth factor in Alzheimer's Disease defective retrograde transport to nucleus bas-alis. Neuroreport.1995;61063~1066
22,Nabeshima T. Nerve growth factor and preparation of animal model for Alzheimer-type senile dementia. Yakugaku Zassi.1995115(7):499~512
33,Kapl D Rudolpli KA.New pharmacologic aspects in the neurol-ogic profile of propentofylline. Tierarztl prax Ausg K KlientiereHeimtiere.199826(5):317~321
44,Charles V. Mufson EJ. Friden PM et al. Atrophy of cholinergicbasal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. BrainRes.1996728193~203
55,Hu L. Cote SL, Cuello AC. Differential modulation of the choliergic phenotype of the nucleus basalis magnocellularis neurons byapplying NGF at the cell body or cortical terminal fields.Exp Ne-urol.1997143(1):162~171
66,Fischer W. Sirevaag A. Wiegand SJ et al. Reversal of spatitalmemory impairments in aged rats by nerve growth factor and neurotrophin-3 and 4/5 but not brain-derived neurotrophic factor.Proc Natl Acad Sci USA.1994918607~8011
77,Lapohak PA. Hefti F. Effects of recombinant human NGF onpresynaptic cholinergic function in rat hippocampal slices foll-owing partial septohippocampal lesions Measuresm of [3H] ac
88,Burgos I. Cuello AC. Liberini P et al. NGF-mediated synapticsprouting in the cerebral cortex of lesioned primate brain.BrainRes.1995692154~160
99,Eriksdotter. JM. Nordberg A. Amberla K et al. Intracerebroven-tricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr cogn Disord.19989(5):246~257
1010,Tuszynski MH. Roberts J. Senut MC et al.Gene therapy in theadult primate brain intraparenchymal grafts of cells geneticallymodified to produce nerve growth factor prevent cholinergic ne-uronal degeneration. Gene Ther.19963(4):305~314